WP
Woodline Partners Portfolio holdings
AUM
$18.9B
This Quarter Return
+4.74%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$5.36B
AUM Growth
+$5.36B
(+19%)
Cap. Flow
+$809M
Cap. Flow
% of AUM
15.09%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168
Top Buys
| 1 |
KLA
KLAC
|
$83.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$83.2M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$58.7M |
| 4 |
Teradyne
TER
|
$58.7M |
| 5 |
AbbVie
ABBV
|
$52.9M |
Top Sells
| 1 |
Danaher
DHR
|
$70.9M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$60.3M |
| 3 |
Zimmer Biomet
ZBH
|
$56.1M |
| 4 |
NVIDIA
NVDA
|
$55.8M |
| 5 |
Qorvo
QRVO
|
$42.8M |
Sector Composition
| 1 | Healthcare | 46.89% |
| 2 | Technology | 25.61% |
| 3 | Communication Services | 8.73% |
| 4 | Financials | 5.37% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ASML
ASML
$290B
| $43.5M | 0.81% |
+62,959
| New | +$43.5M |
|
|
27
Regeneron Pharmaceuticals
REGN
$59.8B
| $43.5M | 0.81% |
77,859
-108,040
| -58% | -$60.3M |
|
28
Snap
SNAP
$12.3B
| $41.5M | 0.77% |
+609,604
| New | +$41.5M |
|
29
Omnicom Group
OMC
$15B
| $40M | 0.75% |
+499,789
| New | +$40M |
|
30
Immunovant
IMVT
$2.91B
| $39.6M | 0.74% |
3,750,575
+2,853,958
| +318% | +$30.2M |
|
|
NATI
31
DELISTED
National Instruments Corp
NATI
| $39.2M | 0.73% |
926,485
+138,859
| +18% | +$5.87M |
|
32
Ionis Pharmaceuticals
IONS
$9.64B
| $38.4M | 0.72% |
963,788
+487,897
| +103% | +$19.5M |
|
33
Lyft
LYFT
$7.02B
| $38.2M | 0.71% |
632,009
+187,329
| +42% | +$11.3M |
|
34
Neurocrine Biosciences
NBIX
$13.5B
| $37.5M | 0.7% |
+385,054
| New | +$37.5M |
|
|
DRNA
35
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $37.3M | 0.7% |
1,000,325
-776,675
| -44% | -$29M |
|
36
Eli Lilly
LLY
$661B
| $36.2M | 0.67% |
157,691
+42,045
| +36% | +$9.65M |
|
37
Skyworks Solutions
SWKS
$10.9B
| $35.8M | 0.67% |
+186,770
| New | +$35.8M |
|
|
38
Danaher
DHR
$143B
| $35.8M | 0.67% |
150,345
-298,091
| -66% | -$70.9M |
|
39
AT&T
T
$208B
| $35M | 0.65% |
1,611,462
+1,271,107
| +373% | +$27.6M |
|
40
Fidelity National Information Services
FIS
$35.6B
| $34.2M | 0.64% |
241,613
-256,511
| -51% | -$36.3M |
|
41
Vertex Pharmaceuticals
VRTX
$102B
| $33.1M | 0.62% |
164,064
-50,012
| -23% | -$10.1M |
|
42
Edwards Lifesciences
EW
$47.7B
| $31.8M | 0.59% |
+307,190
| New | +$31.8M |
|
43
Avantor
AVTR
$8.74B
| $31M | 0.58% |
873,832
-68,112
| -7% | -$2.42M |
|
44
Merck
MRK
$210B
| $30.1M | 0.56% |
386,894
+87,842
| +29% | +$6.83M |
|
|
ARNA
45
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $28.7M | 0.54% |
+420,953
| New | +$28.7M |
|
|
KLRS
46
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.5M
| $28.1M | 0.52% |
61,995
+10,694
| +21% | +$4.86M |
|
47
The Beauty Health Co
SKIN
$254M
| $27.4M | 0.51% |
+1,628,416
| New | +$27.4M |
|
48
Western Digital
WDC
$29.8B
| $27.2M | 0.51% |
505,172
+223,526
| +79% | +$12M |
|
49
Revolution Medicines
RVMD
$7.43B
| $27M | 0.5% |
851,592
+9,530
| +1% | +$302K |
|
50
Zentalis Pharmaceuticals
ZNTL
$123M
| $26.9M | 0.5% |
505,675
+361,514
| +251% | +$19.2M |
|